Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex

Nature
Yi-Lynn LiangDenise Wootten

Abstract

The class B glucagon-like peptide-1 (GLP-1) G protein-coupled receptor is a major target for the treatment of type 2 diabetes and obesity. Endogenous and mimetic GLP-1 peptides exhibit biased agonism-a difference in functional selectivity-that may provide improved therapeutic outcomes. Here we describe the structure of the human GLP-1 receptor in complex with the G protein-biased peptide exendin-P5 and a Gαs heterotrimer, determined at a global resolution of 3.3 Å. At the extracellular surface, the organization of extracellular loop 3 and proximal transmembrane segments differs between our exendin-P5-bound structure and previous GLP-1-bound GLP-1 receptor structure. At the intracellular face, there was a six-degree difference in the angle of the Gαs-α5 helix engagement between structures, which was propagated across the G protein heterotrimer. In addition, the structures differed in the rate and extent of conformational reorganization of the Gαs protein. Our structure provides insights into the molecular basis of biased agonism.

References

Mar 6, 1992·Cell·C H Berlot, H R Bourne
Jan 20, 1999·Proceedings of the National Academy of Sciences of the United States of America·T IiriH R Bourne
Jul 21, 2004·Journal of Computational Chemistry·Eric F PettersenThomas E Ferrin
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Sep 27, 2005·Journal of Structural Biology·David N Mastronarde
Jul 25, 2006·Journal of Structural Biology·Guang TangSteven J Ludtke
Jul 20, 2007·Biochemical Society Transactions·R MannD Donnelly
Feb 22, 2008·The Journal of Biological Chemistry·Steffen RungeRainer Rudolph
Jan 9, 2010·Acta Crystallographica. Section D, Biological Crystallography·Vincent B ChenDavid C Richardson
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Paul D AdamsPeter H Zwart
Mar 13, 2013·Proceedings of the National Academy of Sciences of the United States of America·Denise WoottenPatrick M Sexton
Apr 16, 2013·BioTechniques·Emilia Elizabeth SavageSebastian George Barton Furness
Jul 19, 2013·Nature·Fai Yiu SiuRaymond C Stevens
Jul 19, 2013·Nature·Kaspar HollensteinFiona H Marshall
Oct 22, 2014·Proceedings of the National Academy of Sciences of the United States of America·Radostin DanevWolfgang Baumeister
Oct 29, 2014·Journal of Medicinal Chemistry·Bikash Manandhar, Jung-Mo Ahn
Nov 26, 2015·Journal of Structural Biology·Kai Zhang
Dec 2, 2015·Nature Communications·Hongkai ZhangRichard A Lerner
Jan 29, 2016·Nature Communications·Maryam KhoshoueiRadostin Danev
Oct 22, 2016·Cell·Sebastian George Barton FurnessPatrick Michael Sexton
Nov 5, 2016·Journal of the American Chemical Society·Marlies V HagerSamuel H Gellman
Apr 2, 2017·Biochemical Pharmacology·Marlies V HagerDenise Wootten
Apr 25, 2017·Nature·Yi-Lynn LiangPatrick M Sexton
Jun 1, 2017·Nature·Ali JazayeriFiona H Marshall
Jun 14, 2017·Nature·G Glenn GregorioScott C Blanchard
Jul 1, 2017·Nature Communications·Maryam KhoshoueiRadostin Danev

❮ Previous
Next ❯

Citations

Jun 9, 2018·Nature Reviews. Drug Discovery·Jean-Paul RenaudChristian Wiesmann
May 3, 2018·The Journal of Biological Chemistry·Saifei LeiPatrick M Sexton
Sep 29, 2018·Nature Reviews. Drug Discovery·Adrian P Campbell, Alan V Smrcka
Oct 13, 2018·Protein Science : a Publication of the Protein Society·X Edward ZhouH Eric Xu
Jan 4, 2019·Acta Crystallographica. Section F, Structural Biology Communications·Alok K Mitra
Dec 20, 2018·Chembiochem : a European Journal of Chemical Biology·Lisa SeidelIrene Coin
Jan 3, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Amanda E MackenzieGraeme Milligan
Mar 30, 2019·Basic & Clinical Pharmacology & Toxicology·Gunnar Schulte, Paweł Kozielewicz
May 28, 2019·Journal of Computer-aided Molecular Design·Lee H WinkAbby L Parrill
Jul 12, 2019·Proteins·Raphael Alhadeff, Arieh Warshel
Aug 23, 2019·Cellular and Molecular Life Sciences : CMLS·Alan V Smrcka, Isaac Fisher
Jan 10, 2020·Nature·Peishen ZhaoDenise Wootten
May 7, 2020·The Journal of Biological Chemistry·Rulue ChangPatrick M Sexton
Nov 2, 2019·The FEBS Journal·Janosch EhrenmannAndreas Plückthun
Jun 24, 2020·The Journal of Biological Chemistry·Ieva Sutkeviciute, Jean-Pierre Vilardaga
Aug 30, 2019·Nature Reviews. Drug Discovery·Frederic BassilanaMarie-Gabrielle Ludwig
Dec 7, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Andrea Hembre UlsundK W Andressen
Jul 28, 2019·Annual Review of Pharmacology and Toxicology·Javier García-Nafría, Christopher G Tate
Jul 5, 2019·Nature Structural & Molecular Biology·Bryan L Roth
Oct 9, 2019·Molecular Pharmacology·Pawel KozielewiczGunnar Schulte
Oct 16, 2019·Proceedings of the National Academy of Sciences of the United States of America·Zoltan DekanMacDonald J Christie
Mar 11, 2020·Nature Communications·Fan WuRaymond C Stevens
Jun 24, 2020·Proceedings of the National Academy of Sciences of the United States of America·Giulio MattediFrancesco Luigi Gervasio
Jul 6, 2018·Nature·David M ThalArthur Christopoulos
Mar 20, 2019·Future Medicinal Chemistry·Giuseppe DeganuttiChristopher A Reynolds
Jan 22, 2019·Nature Methods·Christian MunkDavid E Gloriam
Nov 20, 2019·Nature Structural & Molecular Biology·Anthony H NguyenRobert J Lefkowitz
Feb 13, 2020·Cell Research·Jia WangYingli Ma
Jul 8, 2020·Nature Chemical Biology·Lisa J ClarkJean-Pierre Vilardaga
May 29, 2018·Nature Structural & Molecular Biology·Can CaoBeili Wu
Sep 23, 2018·Biochemical Society Transactions·Tracy L NeroCraig J Morton
Sep 15, 2018·Nature Communications·Shoji MaedaBrian K Kobilka
Jan 17, 2019·Biochemical Society Transactions·Tom CeskaPamela A Williams
Dec 5, 2018·Nature Chemical Biology·Martin AudetRaymond C Stevens
Mar 12, 2020·Nature Structural & Molecular Biology·Kazuhiro KobayashiOsamu Nureki
Jul 10, 2020·Cells·Alessandro MatareseGaetano Santulli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.